Trimeth/sulfa

   
Google
 
Web NewDrugInformation.com

Trimeth/sulfa


Drug - Trimeth/sulfa
The trade name of the product as shown on the labeling.

Dosage - SUSPENSION; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Sulfamethoxazole; Trimethoprim
Multiple ingredients are in alphabetical order.

Strength - 200MG/5ML;40MG/5ML
The potency of the active ingredient(s), Sulfamethoxazole; Trimethoprim. May repeat for multiple part products.

Applicant - NASKA
The firm name holding legal responsibility for Trimeth/sulfa. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 072399
The FDA assigned number to Trimeth/sulfa. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Trimeth/sulfa. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 23, 1988
The date Trimeth/sulfa was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Trimeth/sulfa. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Trimeth/sulfa is in. Format is RX, OTC, DISCN.

Applicant Full Name - Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics
The full name of the firm holding legal responsibility for the new application of Trimeth/sulfa.

Trimeth/sulfa